Literature DB >> 17943438

Promotion of neuronal plasticity by (-)-epigallocatechin-3-gallate.

Wen Xie1, Narayan Ramakrishna, Andrzej Wieraszko, Yu-Wen Hwang.   

Abstract

The consumption of (-)-epigallocatechin-3-gallate (EGCG), the major polyphenolic compound found in green tea, has been associated with various neurological benefits including cognitive improvement. The physiological basis for this effect is unknown. In this study, we used synaptic transmission between the CA3 and CA1 regions (Schaffer collateral) of the mouse hippocampus to examine the effects of EGCG on neuronal plasticity. We found that the level of high frequency stimulation-evoked long-term potentiation (LTP) was significantly enhanced when hippocampal slices were pre-incubated with 10 microM EGCG for 1 h prior to the experiment. EGCG incubation also enabled hippocampal slices prepared from Ts65Dn mice, a Down syndrome mouse model deficient in LTP, to express LTP to a level comparable to the normal controls. EGCG treatment did not alter the degree of pair-pulse inhibition; therefore, the enhancement effect of EGCG is unlikely to involve the attenuation of this inhibitory mechanism.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17943438     DOI: 10.1007/s11064-007-9494-7

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  40 in total

Review 1.  Too much of a good thing: mechanisms of gene action in Down syndrome.

Authors:  R H Reeves; L L Baxter; J T Richtsmeier
Journal:  Trends Genet       Date:  2001-02       Impact factor: 11.639

Review 2.  LTP and LTD: an embarrassment of riches.

Authors:  Robert C Malenka; Mark F Bear
Journal:  Neuron       Date:  2004-09-30       Impact factor: 17.173

3.  Stability of tea polyphenol (-)-epigallocatechin-3-gallate and formation of dimers and epimers under common experimental conditions.

Authors:  Shengmin Sang; Mao-Jung Lee; Zhe Hou; Chi-Tang Ho; Chung S Yang
Journal:  J Agric Food Chem       Date:  2005-11-30       Impact factor: 5.279

4.  Evidence that repetitive seizures in the hippocampus cause a lasting reduction of GABAergic inhibition.

Authors:  J Kapur; J L Stringer; E W Lothman
Journal:  J Neurophysiol       Date:  1989-02       Impact factor: 2.714

5.  Polymerase chain reaction method to identify Down syndrome model segmentally trisomic mice.

Authors:  Narayan Ramakrishna; Clifford Meeker; Shuyun Li; Edmund C Jenkins; Julia R Currie; Michael Flory; Beena Lee; Ming S Liu; David L Miller
Journal:  Anal Biochem       Date:  2005-05-15       Impact factor: 3.365

6.  Altered long-term potentiation in the young and old Ts65Dn mouse, a model for Down Syndrome.

Authors:  R J Siarey; J Stoll; S I Rapoport; Z Galdzicki
Journal:  Neuropharmacology       Date:  1997 Nov-Dec       Impact factor: 5.250

7.  Pharmacotherapy for cognitive impairment in a mouse model of Down syndrome.

Authors:  Fabian Fernandez; Wade Morishita; Elizabeth Zuniga; James Nguyen; Martina Blank; Robert C Malenka; Craig C Garner
Journal:  Nat Neurosci       Date:  2007-02-25       Impact factor: 24.884

8.  Spatial memory deficits in segmental trisomic Ts65Dn mice.

Authors:  G E Demas; R J Nelson; B K Krueger; P J Yarowsky
Journal:  Behav Brain Res       Date:  1996-12       Impact factor: 3.332

9.  Developmental abnormalities and age-related neurodegeneration in a mouse model of Down syndrome.

Authors:  D M Holtzman; D Santucci; J Kilbridge; J Chua-Couzens; D J Fontana; S E Daniels; R M Johnson; K Chen; Y Sun; E Carlson; E Alleva; C J Epstein; W C Mobley
Journal:  Proc Natl Acad Sci U S A       Date:  1996-11-12       Impact factor: 11.205

Review 10.  Cell signaling pathways in the neuroprotective actions of the green tea polyphenol (-)-epigallocatechin-3-gallate: implications for neurodegenerative diseases.

Authors:  Silvia Mandel; Orly Weinreb; Tamar Amit; Moussa B H Youdim
Journal:  J Neurochem       Date:  2004-03       Impact factor: 5.372

View more
  23 in total

1.  EGCG ameliorates the suppression of long-term potentiation induced by ischemia at the Schaffer collateral-CA1 synapse in the rat.

Authors:  Jie Ding; Gang Fu; Yan Zhao; Zhenyong Cheng; Yang Chen; Bo Zhao; Wei He; Lian-Jun Guo
Journal:  Cell Mol Neurobiol       Date:  2011-11-11       Impact factor: 5.046

Review 2.  Prospects for improving brain function in individuals with Down syndrome.

Authors:  Alberto C S Costa; Jonah J Scott-McKean
Journal:  CNS Drugs       Date:  2013-09       Impact factor: 5.749

Review 3.  The role of DYRK1A in neurodegenerative diseases.

Authors:  Jerzy Wegiel; Cheng-Xin Gong; Yu-Wen Hwang
Journal:  FEBS J       Date:  2010-12-13       Impact factor: 5.542

4.  Novel Epigenetic Regulation of Alpha-Synuclein Expression in Down Syndrome.

Authors:  Narayan Ramakrishna; Harry C Meeker; W Ted Brown
Journal:  Mol Neurobiol       Date:  2014-11-23       Impact factor: 5.590

5.  Epigallocatechin gallate: A useful therapy for cognitive disability in Down syndrome?

Authors:  Fiorenza Stagni; Andrea Giacomini; Marco Emili; Sandra Guidi; Elisabetta Ciani; Renata Bartesaghi
Journal:  Neurogenesis (Austin)       Date:  2017-02-02

Review 6.  Molecular basis of pharmacotherapies for cognition in Down syndrome.

Authors:  Katheleen J Gardiner
Journal:  Trends Pharmacol Sci       Date:  2009-12-04       Impact factor: 14.819

7.  Delayed Treatment with Green Tea Polyphenol EGCG Promotes Neurogenesis After Ischemic Stroke in Adult Mice.

Authors:  Jian-Cheng Zhang; Hang Xu; Yin Yuan; Jia-Yi Chen; Yu-Jing Zhang; Yun Lin; Shi-Ying Yuan
Journal:  Mol Neurobiol       Date:  2016-05-20       Impact factor: 5.590

Review 8.  Exercise and the brain: something to chew on.

Authors:  Henriette van Praag
Journal:  Trends Neurosci       Date:  2009-04-06       Impact factor: 13.837

Review 9.  Mouse models of Down syndrome as a tool to unravel the causes of mental disabilities.

Authors:  Noemí Rueda; Jesús Flórez; Carmen Martínez-Cué
Journal:  Neural Plast       Date:  2012-05-22       Impact factor: 3.599

10.  Green tea polyphenols rescue of brain defects induced by overexpression of DYRK1A.

Authors:  Fayçal Guedj; Catherine Sébrié; Isabelle Rivals; Aurelie Ledru; Evelyne Paly; Jean C Bizot; Desmond Smith; Edward Rubin; Brigitte Gillet; Mariona Arbones; Jean M Delabar
Journal:  PLoS One       Date:  2009-02-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.